FDA inspection
Aurobindo Pharma Limited (Unit I): FDA inspection ending Apr 22, 2004
FDA inspection 328611 · No Action Indicated (NAI) · Doultabad
Key facts
| Inspection ID | 328611 |
|---|---|
| Firm | Aurobindo Pharma Limited (Unit I) |
| FEI number | 3004021253 |
| Address | Unit - I, 385 386 388 - 396 Survey 379 |
| City | Doultabad |
| Fiscal year | 2004 |
| Inspection end date | Apr 22, 2004 |
| Classification | No Action Indicated (NAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data